|
NZ252051A
(en)
|
1992-05-19 |
1996-10-28 |
Graham Edmund Kelly |
Health supplement comprising a phyto-oestrogen selected from genistein, daidzein, biochanin and/or formononetin
|
|
AUPN166195A0
(en)
|
1995-03-13 |
1995-04-06 |
Norvet Research Pty Limited |
Process for glucan extraction
|
|
AUPO203996A0
(en)
|
1996-08-30 |
1996-09-26 |
Novogen Research Pty Ltd |
Therapeutic uses
|
|
US20050058709A1
(en)
*
|
1997-06-04 |
2005-03-17 |
Fisher Gary J. |
Methods for inhibiting photoaging of human skin using orally-administered agent
|
|
TWI234467B
(en)
*
|
1997-06-04 |
2005-06-21 |
Univ Michigan |
Composition for inhibiting photoaging of skin
|
|
US6060070A
(en)
*
|
1997-06-11 |
2000-05-09 |
Gorbach; Sherwood L. |
Isoflavonoids for treatment and prevention of aging skin and wrinkles
|
|
US8039026B1
(en)
|
1997-07-28 |
2011-10-18 |
Johnson & Johnson Consumer Companies, Inc |
Methods for treating skin pigmentation
|
|
AUPP112497A0
(en)
*
|
1997-12-24 |
1998-01-22 |
Novogen Research Pty Ltd |
Compositions and method for protecting skin from UV induced immunosupression and skin damage
|
|
WO1999047118A1
(en)
*
|
1998-03-16 |
1999-09-23 |
The Procter & Gamble Company |
Compositions for regulating skin appearance
|
|
US6683069B1
(en)
|
1998-04-02 |
2004-01-27 |
Regents Of The University Of Michigan |
Methods and compositions for reducing UV-induced inhibition of collagen synthesis in human skin
|
|
TWI234455B
(en)
*
|
1998-04-02 |
2005-06-21 |
Univ Michigan |
Methods and compositions for reducing UV-induced inhibition of collagen synthesis in human skin
|
|
US6750229B2
(en)
|
1998-07-06 |
2004-06-15 |
Johnson & Johnson Consumer Companies, Inc. |
Methods for treating skin pigmentation
|
|
US8093293B2
(en)
|
1998-07-06 |
2012-01-10 |
Johnson & Johnson Consumer Companies, Inc. |
Methods for treating skin conditions
|
|
US8106094B2
(en)
|
1998-07-06 |
2012-01-31 |
Johnson & Johnson Consumer Companies, Inc. |
Compositions and methods for treating skin conditions
|
|
FR2781154B1
(fr)
*
|
1998-07-15 |
2001-09-07 |
Lafon Labor |
Composition therapeutique a base d'isoflavonoides destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques
|
|
US20040131579A1
(en)
*
|
1998-09-10 |
2004-07-08 |
Avon Products, Inc. |
Method and compositions for reducing dermatological aging and for reducing bruising
|
|
DE69932621D1
(de)
*
|
1998-10-09 |
2006-09-14 |
Yakult Honsha Kk |
Hautpflegezubereitungen zur äusseren anwendung
|
|
US6399107B1
(en)
|
1998-12-22 |
2002-06-04 |
Alcon Laboratories, Inc. |
Use of inhibitors of gag synthesis for the treatment of corneal haze
|
|
US7985404B1
(en)
|
1999-07-27 |
2011-07-26 |
Johnson & Johnson Consumer Companies, Inc. |
Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
|
|
US7309688B2
(en)
|
2000-10-27 |
2007-12-18 |
Johnson & Johnson Consumer Companies |
Topical anti-cancer compositions and methods of use thereof
|
|
JP2001131052A
(ja)
*
|
1999-11-09 |
2001-05-15 |
Shinei Ferumentekku:Kk |
化粧品
|
|
JP2001131081A
(ja)
|
1999-11-09 |
2001-05-15 |
Shinei Ferumentekku:Kk |
スーパーオキサイド消去剤および飲料
|
|
ATE363902T1
(de)
*
|
2000-06-14 |
2007-06-15 |
Us Health |
Isoflavonen gegen strahlungsinduzierte mortalität
|
|
EP1414436A1
(en)
*
|
2000-06-14 |
2004-05-06 |
Alla Shapiro |
Radioprotective agents
|
|
JP2004504276A
(ja)
*
|
2000-06-26 |
2004-02-12 |
ザ、リージェンツ、オブ、ザ、ユニバーシティ、オブ、ミシガン |
ヒトの皮膚の光老化を防止するためのｅｇｆ−ｒタンパク質チロシンキナーゼ抑制剤の使用
|
|
AU7131001A
(en)
*
|
2000-08-08 |
2001-12-24 |
Us Health |
Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection against and treatment of radiation injury
|
|
FR2815861B1
(fr)
*
|
2000-10-26 |
2003-02-28 |
Oreal |
Utilisation de l'association d'au moins un carotenoide et d'au moins un isoflavonoide pour traiter les signes cutanes du vieillissement
|
|
US8431550B2
(en)
|
2000-10-27 |
2013-04-30 |
Johnson & Johnson Consumer Companies, Inc. |
Topical anti-cancer compositions and methods of use thereof
|
|
FR2820974B1
(fr)
*
|
2001-02-21 |
2004-02-13 |
Pharmascience Lab |
Composition topique comprenant une solution vraie contenant un derive de chromane ou de chromene, son procede de preparation et son utilisation cosmetique et therapeutique
|
|
EP1234572B1
(de)
|
2001-02-26 |
2013-10-30 |
Mibelle AG Cosmetics |
Isoflavon-Aglykone enhaltende Hautbehandlungsmittel
|
|
AU2002255627B2
(en)
*
|
2001-02-27 |
2008-01-17 |
The Regents Of The University Of Michigan |
Use of natural EGFR inhibitors to prevent side effects due to retinoid therapy, soaps, and other stimuli that activate the epidermal growth receptor
|
|
US6555143B2
(en)
|
2001-02-28 |
2003-04-29 |
Johnson & Johnson Consumer Products, Inc. |
Legume products
|
|
US20020160061A1
(en)
*
|
2001-02-28 |
2002-10-31 |
Claude Saliou |
Use of legume products for the treatment of external aggressions
|
|
US7192615B2
(en)
|
2001-02-28 |
2007-03-20 |
J&J Consumer Companies, Inc. |
Compositions containing legume products
|
|
JP4901024B2
(ja)
*
|
2001-06-22 |
2012-03-21 |
株式会社ナリス化粧品 |
８−ＯＨｄＧ（８−ハイドロキシデオキシグアノシン）産生抑制剤
|
|
JP4901025B2
(ja)
*
|
2001-06-22 |
2012-03-21 |
株式会社ナリス化粧品 |
エラスターゼ阻害剤
|
|
EP1321123A1
(de)
*
|
2001-12-20 |
2003-06-25 |
Cognis France S.A. |
Verwendung eines Extraktes der Pflanze Baptisia tinctoria in einer kosmetischen Zusammensetzung
|
|
JP2005535614A
(ja)
*
|
2002-06-25 |
2005-11-24 |
コズメシューティック ソリューションズ プロプライエタリー リミテッド |
局所用美容組成物
|
|
DE50205310D1
(de)
*
|
2002-06-29 |
2006-01-19 |
Aquanova Ger Solubilisate Tech |
Isoflavonkonzentrate sowie verfahren zu ihrer herstellung
|
|
DE20213787U1
(de)
*
|
2002-09-04 |
2002-12-19 |
Warner-Lambert Co., Morris Plains, N.J. |
Hautpflegemittel
|
|
DE10301631A1
(de)
*
|
2003-01-17 |
2004-07-29 |
Beiersdorf Ag |
Kosmetische und dermatologische Zubereitungen mit einem Gehalt an Sojabohnenkeimextrakten in Kombination mit Vitamin C und/oder E sowie alpha-Glycosylrutin
|
|
US7718813B2
(en)
|
2003-08-15 |
2010-05-18 |
Nature Pure Labs Sw, Inc. |
Hydrolysis and purification of active plant compounds suitable for topical application
|
|
ATE520396T1
(de)
*
|
2005-06-29 |
2011-09-15 |
Dsm Ip Assets Bv |
Isoflavon-nanoteilchen und ihre verwendung
|
|
BRPI0612705A2
(pt)
*
|
2005-06-29 |
2010-11-30 |
Dsm Ip Assets Bv |
composições tópicas compreendendo nanopartìculas de uma isoflavona
|
|
US9345649B2
(en)
|
2006-12-21 |
2016-05-24 |
Avon Products, Inc. |
Cosmetic composition containing novel fractal particle-based gels
|
|
FR2915384B1
(fr)
*
|
2007-04-27 |
2010-01-15 |
Vincience |
Utilisation d'un principe actif issu du soja (glycine maxl.) pour preparer une composition destinee a activer l'energie cellulaire et a proteger la peau des dommages oxydatifs.
|
|
FR2915381B1
(fr)
*
|
2007-04-27 |
2012-06-08 |
Vincience |
Utilisation d'un principe actif issu du soja (glycine max l) pour preparer une composition destinee a activer le cytochrome c
|
|
FR2915378B1
(fr)
*
|
2007-04-27 |
2009-08-21 |
Vincience Sa |
Utilisation d'un principe actif issu du soja (glycine max l.) pour preparer une composition destinee a proteger les mitochondries
|
|
TWI411448B
(zh)
*
|
2007-12-27 |
2013-10-11 |
Avon Prod Inc |
適合用於化妝品之光學模糊色素組合物
|
|
EP2506829A4
(en)
*
|
2009-12-04 |
2014-05-14 |
Avon Prod Inc |
TOPICAL COMPOSITIONS CONTAINING DERRIS SCANDENS BENTH. AND METHOD FOR SKIN TREATMENT
|
|
IT1401364B1
(it)
*
|
2010-07-09 |
2013-07-18 |
Rottapharm Spa |
Composizioni dermocosmetiche per protezione solare
|
|
US9623003B1
(en)
|
2013-04-04 |
2017-04-18 |
Humanetics Corporation |
Method of mitigating long and short term detrimental effects of exposure to medical imaging ionizing radiation by administration of genistein
|